Radiotherapy in practice - radioisotope therapy
Series: Radiotherapy in Practice;
- Publisher's listprice GBP 89.00
-
40 183 Ft (38 270 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 4 018 Ft off)
- Discounted price 36 165 Ft (34 443 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
40 183 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP Oxford
- Date of Publication 8 February 2007
- ISBN 9780198568421
- Binding Paperback
- No. of pages200 pages
- Size 233x156x17 mm
- Weight 348 g
- Language English
- Illustrations 14 halftones, 2 pp colour plates, 6 line illustrations, tables 0
Categories
Short description:
Radioisotope therapy is an internal form of radiation, administered through liquid or injection, that treats cancer with minimal damage to the normal surrounding tissue. This book is a practical guide to radioisotope therapy, taking the reader through the basic principles, and then developing this by application to specific sites and diseases.
MoreLong description:
Radioisotope therapy is an internal form of radiation used to treat cancer; it may be administered orally or intravenously and represents the nearest treatment option to the 'magic bullet', specifically targeting sites of disease whilst sparing surrounding normal tissues. Radioisotope therapy has an important role to play in modern medicine, particularly in the treatment of thyroid disease, neuroendocrine tumours, bone metastasis and non-Hodgkin's lymphoma. It is found in both the diagnostic setting and in therapy, but recently there has been a renaissance in the application of radioisotope unsealed sources in therapeutic indications. It is an active area of research, with the quest for new compounds that will be specific for therapeutic targets.
This book is an essential, practical guide to the use of radioisotope therapy, and also includes the background and developmental biology which underpins its use. Individual tumours and diseases are explored, with specific focus given to radioisotope treatment options. The barriers to radioisotope therapy, such as ease of access, acquisition of radioisotopes, radiation protection regulations, and cost are also discussed.
ABOUT THE SERIES
Radiotherapy remains the major non-surgical treatment modality for the management of malignant disease, with over 50% of patients receiving treatment at some time during the management of their malignant disease. It is based on the application of the principles of applied physics, radiobiology, and tumour biology to clinical practice. Each volume in this series takes the reader through the basic principles of different types of radiotherapy, and then develops these by individual sites. This series of practical handbooks are aimed at physicians both training and practising in radiotherapy, as well as medical physicists, dosimetrists, radiographers and senior nurses.
...an essential, practical guide to the use of radioisotope therapy, and also includes the background and developmental biology which underpins its use. Individual tumours and diseases are explored, with specific focus given to radioiodine (I131) and monoclonal antibodies as treatment options. The barriers to radioisotope therapy, such as ease of access, acquisition of radioisotopes, radiation protection, and cost are also discussed.
Table of Contents:
Physics principles in the clinical use of radioisotopes
Antibody directed radioisotope therapy
Radiotherapy for benign thyroid disease: use of I131
Malignant thyroid disease: use of I131
Neuroendocrine tumours
Radioisotope therapy for metastatic bone disease
Radioimmunotherapy for lymphoma
Other therapeutic use of radioisotopes
Radioprotection and regulatory aspects of radioisotope therapy
